Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting DTX2/UFD1-mediated FTO degradation to regulate antitumor immunity

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2407910121Source: DataRank Database

Targeting DTX2/UFD1-mediated FTO degradation to regulate antitumor immunity is a research paper published in Proceedings of the National Academy of Sciences (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

geo pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 1.72)OA: hybridTopics (39)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Jiangbo Wei ORCID,Hao Fan ORCID,Wenlong Li ORCID,Lijie Zhao ORCID,Emma Wilkinson ORCID

Live enrichment

PubMed:39661064 PMC:PMC11665913 OpenAlex:https://openalex.org/W4405288640

HHS | NIH | National Institute of Environmental Health Sciences

Grant: ES031693 ES031534 ES030576

NCI NIH HHS

Grant: P30 CA014599

NIEHS NIH HHS

Grant: R01 ES031534

NIH HHS

Grant: S10 OD027016

NCI NIH HHS

Grant: T32 CA009594

NIEHS NIH HHS

Grant: P30 ES027792

NIEHS NIH HHS

Grant: R01 ES030576

NIEHS NIH HHS

Grant: R35 ES031693

FWCI

1.72

Citation Percentile

0.8%

Citation Trend

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1073/pnas.2407910121

publisherhttps://doi.org/10.1073/pnas.2407910121

publisherhttps://pnas.org/doi/pdf/10.1073/pnas.2407910121

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39661064

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11665913

Fields of Study

RNA modifications and cancerCancer-related gene regulationCancer-related molecular mechanisms researchAlpha-Ketoglutarate-Dependent Dioxygenase FTOAnimalsMiceHumansUbiquitin-Protein LigasesCell Line, TumorUbiquitinationProteolysisImmunotherapyNeoplasmsMice, Inbred C57BL

MeSH Terms

Alpha-Ketoglutarate-Dependent Dioxygenase FTOAnimalsHumansImmunotherapyMice, Inbred C57BLNeoplasmsUbiquitin-Protein LigasesCell Line, TumorMiceUbiquitinationProteolysis

Keywords

Degradation (telecommunications)ImmunityCancer researchChemistryCell biologyBiologyImmune systemComputer scienceImmunologyFtoUfd1Dtx2M6a Rna MethylationUbiquitin-mediated Proteasomal Degradation

Sustainable Development Goals

SDG 0: Good health and well-being

Targeting DTX2/UFD1-mediated FTO degradation to regulate antitumor immunity

FAIR Checklist

Authors (15)

Funding (8 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)